Related Experiment Video
Updated: Apr 18, 2026
07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.9K
Microarray technology to investigate genes associated with papillary thyroid carcinoma.
Xinyong Zhu1, Jing Yao1, Wen Tian1
1Department of Gastrointestinal Surgery, The First Hospital Affiliated to General Hospital of PLA, Beijing 100048, P.R. China.
Molecular Medicine Reports
|January 15, 2015
Summary
This study identified key regulatory genes and networks in papillary thyroid carcinoma (PTC) using DNA microarray data. These findings offer insights into PTC development and potential clinical applications.
Area of Science:
- Genomics
- Molecular Biology
- Oncology
Background:
- Papillary thyroid carcinoma (PTC) is a prevalent endocrine malignancy.
- Understanding the molecular mechanisms and regulatory networks in PTC is crucial for effective treatment.
Purpose of the Study:
- To investigate regulatory genes and the underlying network in PTC.
- To identify differentially expressed genes (DEGs) and transcription factors in PTC tissues.
Main Methods:
- Downloaded and analyzed DNA microarray data (GSE3678) from PTC and healthy thyroid samples.
- Identified DEGs using R packages and performed gene regulation analysis with TRANSFAC® and TRED.
- Established a regulatory network and conducted pathway enrichment analysis using DAVID.
Main Results:
- Identified 171 DEGs and constructed a regulatory network with 104 DEGs.
- Discovered three differentially expressed transcription factors: Trefoil factor 3, cut‑like homeobox 2, and forkhead box protein A2.
- Pathway analysis revealed significant involvement in cancer pathways, gene expression regulation, and metabolic processes.
Conclusions:
- Identified novel genes associated with PTC development.
- Provided insights into PTC regulatory mechanisms, aiding in clinical diagnostic and therapeutic strategies.
